20 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 35396013 | Lodenafil. | 2022 | 1 | ||
2 | 26027619 | PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial. | 2015 Jun | 1 | ||
3 | 24868160 | Udenafil for the treatment of erectile dysfunction. | 2014 | 1 | ||
4 | 24987176 | Concentration-dependent differential effects of udenafil on viability, proliferation, and apoptosis in vascular endothelial and smooth muscle cells. | 2014 May-Jun | 1 | ||
5 | 25189168 | Baseline MRA predicts the treatment response to vasodilator udenafil in patients with secondary Raynaud's phenomenon. | 2014 Nov-Dec | 1 | ||
6 | 23656343 | Phosphodiesterase inhibitors in clinical urology. | 2013 May | 1 | ||
7 | 23785019 | Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study. | 2013 Jul | 1 | ||
8 | 23799908 | ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial. | 2013 Jun 22 | 1 | ||
9 | 26558086 | Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. | 2013 Sep | 1 | ||
10 | 22644853 | Solid state of a new PDE-5 inhibitor DA-8159: characterization, dissolution, transformation. | 2012 May | 2 | ||
11 | 22946546 | Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study. | 2012 Aug | 3 | ||
12 | 21054754 | Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. | 2011 Jun | 1 | ||
13 | 21460862 | Prevalence and medical management of erectile dysfunction in Asia. | 2011 Jul | 1 | ||
14 | 19660002 | Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. | 2009 Jul | 2 | ||
15 | 19860692 | PDE5 inhibitors: in vitro and in vivo pharmacological profile. | 2009 | 2 | ||
16 | 18197727 | Looking to the future for erectile dysfunction therapies. | 2008 | 1 | ||
17 | 18221288 | The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. | 2008 Apr | 3 | ||
18 | 18318773 | Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. | 2008 Jun | 2 | ||
19 | 16869121 | Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. | 2006 Jul | 2 | ||
20 | 12510841 | Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. | 2002 Dec | 5 |